In an intriguing TED-style presentation by Dr. Greg Petsko at this week’s Massachusetts Life Sciences Start-up Initiative convention, the renowned Brandeis/Harvard professor and co-founder of combinatorial chemistry pioneer ArQule, issued a throw-down:
“We need a way to persuade drug companies to part with these compounds and let them be tested on a broad spectrum of diseases so that we can actually find alternative uses.”